Yuekang Pharmaceutical (688658.SH) subsidiary YKYY029 injection has obtained FDA clinical trial approval.

Zhtng Cijng APP News, Ykng Yoy (688658.SH) released an announcement, the company's subsidiary Beijing Ykng Kchung Yoy Kj Gfn Yuxin Gngs (referred to as "Ykng Kchung") recently received a letter from the United States Food and Drug Administration (referred to as "FDA") agreeing to conduct clinical trials for YKYY029 injection for the treatment of hypertension (Study May Proceed Letter, IND number: 176571).